Loading clinical trials...
Loading clinical trials...
Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
HonorHealth Research Institute
NCT07502976 · Androgenic Alopecia
NCT07029711 · Severe Alopecia Areata
NCT07435012 · Androgenic Alopecia
NCT07080931 · Androgenetic Alopecia
NCT06826196 · Alopecia Areata (AA)
HonorHealth Research Institute
Scottsdale, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions